e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Paediatric asthma: markers and molecules
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association of
FCER2
polymorphism with IgE levels and exacerbations in asthmatic children
V. Giubergia, V. Araoz, C. Castaños, L. Chertkoff (Buenos Aires, Argentina)
Source:
International Congress 2014 – Paediatric asthma: markers and molecules
Session:
Paediatric asthma: markers and molecules
Session type:
Thematic Poster Session
Number:
4209
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Giubergia, V. Araoz, C. Castaños, L. Chertkoff (Buenos Aires, Argentina). Association of
FCER2
polymorphism with IgE levels and exacerbations in asthmatic children. Eur Respir J 2014; 44: Suppl. 58, 4209
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
VDR and VDBP polymorphisms are associated with 25(OH)D
3
levels in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Genetic polymorphisms in early and late-onset bronchial asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Investigating the role of BAFF in murine models of allergic asthma
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Variability of total serum IgE in moderate-to-severe asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Influence of maternal bronchial asthma clinical phenotype on development of allergies in children
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Allergen microarray detection of specific IgE in southern Chinese pollen allergy patients
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Vitamin D status and lung function in children with asthma
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Vitamin D levels and bronchial obstruction in childhood
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Fungal sensitization in patients with moderate and severe asthma
Source: International Congress 2014 – Clinical allergy
Year: 2014
Asthma and IgE associated polymorphisms influence T
H
17 pathway gene expression
Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology
Year: 2014
Risk factors for poor asthma control in asthmatic children
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Identifying risk factors for bronchial asthma in children
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
25(OH) vitamin D levels in pediatric asthma and allergic rhinitis
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Proteins regulating iron metabolism in asthmatic children
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
IL-33
polymorphisms are associated with increased risk of hay fever and reduced regulatory T cells in childhood: The PASTURE/EFRAIM study
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
An international comparison of eczema prevalence in infants, and the association with wheezing
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014
Association between control of rhinitis and control of asthma as assessed by validated questionnaires
Source: International Congress 2014 – Clinical allergy
Year: 2014
How do children with asthma interact with parents about medications?
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept